The Angelini Pharma Inc. Team

Philippe Befferal, BA, General Manager
Mr. Befferal joined Angelini US as CFO in 2011 for the launch of OleptroTM in the US market, he was promoted General Manager of the US operations on January 1st, 2018. Mr. Befferal brings over 20 years of experience in the pharmaceutical industry both at the Corporate and Subsidiary level in international environments. Prior to joining Angelini Mr. Befferal was employed by Patheon (a leading provider of contract drug development and manufacturing services) at their European headquarters in Switzerland as Director of Quotations and Reporting Europe. From 1995 to 2005 Mr. Befferal held several positions at Lundbeck (a leading company in the CNS Market) including Finance Director of the French subsidiary in Paris, Business Support Manager Europe at the headquarters in Copenhagen, Finance Director South Europe in Rome and Senior Director US Admin Operations in New York. Mr. Befferal is a French citizen and speaks French, Italian and English and has extensive knowledge in global commercial operations projects such as customer relationship management implementation, Balanced Scorecard model roll-out, Sales Force expansion and business intelligence tools implementation.

Steven Adler, BS, Director, Sales and Marketing
Mr. Adler has accumulated more than 30 years of experience in marketing, sales and sales management. Mr. Adler joined Angelini Pharma Inc. in 2006, having previously worked for Nephros Inc. as the Director of Marketing with international responsibilities. In 2012 he was appointed manager/leader of the Device Division and the newly formed Wound Care Division. Mr. Adler has a BS in Biology from City College of New York.

Valeria Sena-Weltin, MS, RAC, Manager, Quality Assurance (QA) and Regulatory Affairs (RA)
Mrs. Sena-Weltin brings over 12 years of experience in the regulatory field from various backgrounds, including the medical device and pharmaceutical industry, consulting, with experience from product conceptualization, non-clinical testing, GLP/GCP/GMP ad GDP compliance, product registration in the US, Asia, Latin America, and ROW, to setting up a manufacturing facility for a Class 3 device. Mrs. Sena-Weltin joined Angelini in 2015 as a Regulatory Affairs Specialist and was promoted to lead the Quality and the Regulatory team as Manager of QA and RA. She has earned an BS in Biology, MS in Bioscience, a certificate in Biotech-Enterprise from the Johns Hopkins University.